Lymphoma Steering Committee

The NCI Lymphoma Steering Committee (LYSC) was established in 2009. At monthly meetings, it addresses the design, prioritization, and evaluation of concepts for phase II and phase III clinical trials in adult lymphoma. View the LYSC member roster.

Strategic Priorities

  • LYSC Strategic Priorities were formulated with the goal that the majority of submitted concepts would align with the established priorities. They address areas of unmet clinical need, important unanswered clinical questions, and potential new approaches to disease treatment.

Clinical Trials Planning Meetings (CTPMs)

CTPMs are held periodically and focus on specific clinical trial related topics. The following are important LYSC CTPMs:

Contact

For more information, contact Lawrence Baizer, Ph.D. at baizerl@mail.nih.gov.